Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy.

Singer ST, Kuypers F, Fineman J, Gildengorin G, Larkin S, Sweeters N, Rosenfeld H, Kurio G, Higa A, Jeng M, Huang J, Vichinsky EP.

Ann Hematol. 2014 Jul;93(7):1139-48. doi: 10.1007/s00277-014-2037-9. Epub 2014 Feb 28.

2.

Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis.

Srihirun S, Tanjararak N, Chuncharunee S, Sritara P, Kaewvichit R, Fucharoen S, Pattanapanyasat K, Sibmooh N.

Thromb Res. 2015 Jan;135(1):121-6. doi: 10.1016/j.thromres.2014.10.010. Epub 2014 Oct 18.

PMID:
25455999
3.

Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report.

Morris CR, Kim HY, Trachtenberg F, Wood J, Quinn CT, Sweeters N, Kwiatkowski JL, Thompson AA, Giardina PJ, Boudreaux J, Olivieri NF, Porter JB, Neufeld EJ, Vichinsky EP; Thalassemia Clinical Research Network.

Blood. 2011 Oct 6;118(14):3794-802. doi: 10.1182/blood-2010-11-319152. Epub 2011 Jul 19.

4.

Asymmetric dimethylarginine levels in children with β-thalassemia and their correlations to tricuspid regurgitant jet velocity.

Mohamed el-S, Ibrahim B, Amr D, Noha el-K, Mokhtar M.

Pediatr Blood Cancer. 2014 Sep;61(9):1540-3. doi: 10.1002/pbc.25076. Epub 2014 Apr 21.

PMID:
24753210
5.

Pulmonary hypertension in well-transfused thalassemia major patients.

Meloni A, Detterich J, Pepe A, Harmatz P, Coates TD, Wood JC.

Blood Cells Mol Dis. 2015 Feb;54(2):189-94. doi: 10.1016/j.bcmd.2014.11.003. Epub 2014 Nov 24.

6.

Pulmonary Hypertension in Children With β Thalassemia Major, Are Splenectomy and High-Ferritin Levels Related or Not?

Dedeoglu S, Bornaun H.

J Pediatr Hematol Oncol. 2017 May;39(4):259-265. doi: 10.1097/MPH.0000000000000803.

PMID:
28234742
7.

Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.

Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A.

Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730.

PMID:
18381543
8.

Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.

Minniti CP, Sable C, Campbell A, Rana S, Ensing G, Dham N, Onyekwere O, Nouraie M, Kato GJ, Gladwin MT, Castro OL, Gordeuk VR.

Haematologica. 2009 Mar;94(3):340-7. doi: 10.3324/haematol.13812. Epub 2009 Feb 11.

9.

The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients.

Agha H, El Tagui M, El Ghamrawy M, Abdel Hady M.

Ann Hematol. 2014 Jul;93(7):1131-8. doi: 10.1007/s00277-014-2030-3. Epub 2014 Feb 22.

PMID:
24562420
10.

Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.

El-Shanshory M, Badraia I, Donia A, Abd El-Hameed F, Mabrouk M.

Eur J Haematol. 2013 Jul;91(1):55-61. doi: 10.1111/ejh.12114. Epub 2013 May 3.

PMID:
23551575
11.

Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.

Desai PC, May RC, Jones SK, Strayhorn D, Caughey M, Hinderliter A, Ataga KI.

Br J Haematol. 2013 Sep;162(6):836-41. doi: 10.1111/bjh.12453. Epub 2013 Jul 6.

13.

Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.

Ambrusko SJ, Gunawardena S, Sakara A, Windsor B, Lanford L, Michelson P, Krishnamurti L.

Pediatr Blood Cancer. 2006 Dec;47(7):907-13.

PMID:
16496290
14.

Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Armstrong GT, Joshi VM, Zhu L, Srivastava D, Zhang N, Ness KK, Stokes DC, Krasin MT, Fowler JA, Robison LL, Hudson MM, Green DM.

J Clin Oncol. 2013 Feb 20;31(6):774-81. doi: 10.1200/JCO.2012.43.0702. Epub 2013 Jan 7.

15.

Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease.

Detterich JA, Kato RM, Rabai M, Meiselman HJ, Coates TD, Wood JC.

Blood. 2015 Aug 6;126(6):703-10. doi: 10.1182/blood-2014-12-614370. Epub 2015 Jun 2.

16.

N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.

Mokhtar GM, Adly AA, El Alfy MS, Tawfik LM, Khairy AT.

Hemoglobin. 2010;34(1):78-94. doi: 10.3109/03630260903554621.

PMID:
20113292
17.

Echocardiography-derived tricuspid regurgitant jet velocity is an important marker for the progression of sickle-cell disease.

Upadhya B, Stacey RB, Ntim W, Knovich MA, Pu M.

Acta Haematol. 2014;132(2):152-8.

PMID:
24577318
18.

Prevalence of pulmonary hypertension in hereditary spherocytosis.

Crary SE, Ramaciotti C, Buchanan GR.

Am J Hematol. 2011 Dec;86(12):E73-6. doi: 10.1002/ajh.22182. Epub 2011 Sep 26.

19.

Pulmonary hypertension risk in patients with hemoglobin h disease: low incidence and absence of correlation with splenectomy.

Yin XL, Zhang XH, Wu ZK, Zhao DH, Zhou YL, Yu YH, Liu TN, Fang SP, Zhou TH, Wang L, Huang J.

Acta Haematol. 2013;130(3):153-9. doi: 10.1159/000347177. Epub 2013 May 22.

PMID:
23711936
20.

Echocardiographic evaluation of thalassemia intermedia patients in Duhok, Iraq.

Mohammad AM.

BMC Cardiovasc Disord. 2014 Dec 11;14:183. doi: 10.1186/1471-2261-14-183.

Supplemental Content

Support Center